BAD HOMBURG, Germany, Feb. 5, 2024
/PRNewswire/ -- Fresenius Medical Care (FME), the world's leading
provider of products and services for individuals with renal
diseases, has nominated six employee representatives as members of
the company's Supervisory Board. Effective January 26, the competent court approved the
company's application for the judicial appointment of the six
employee representatives. The judicial appointment will remain
effective until completion of the election of employee
representatives by the FME workforce located in Germany.
Fresenius Medical Care successfully completed its change of
legal form into a German stock corporation (Aktiengesellschaft, AG)
on November 30, 2023, which also
included the formation of a new Supervisory Board, which initially
consisted of the six shareholder representatives. With the
appointment of the six employee representatives, the Supervisory
Board now has full and equal representation. The Board comprises
six women and six men and is well above the statutory minimum
gender quota for the Supervisory Board of 30 percent each.
The employee representatives of the Supervisory Board include
four FME employees, including the representative for executive
employees in Germany, and two
representatives of the Industriegewerkschaft Bergbau, Chemie,
Energie (IGBCE / Industrial Union of Mining, Chemistry, Energie).
The appointed members of the Supervisory Board are:
- Stefanie Balling,
Chairwoman of the General Works Council of Fresenius Medical Care
in Germany, and Chairwoman of the
local works council at the Schweinfurt site (Care Enablement)
- Beate Haßdenteufel, Deputy Chairwoman of the Works
Council at the St. Wendel site (Care Enablement)
- Frank Michael Prescher, Chairman of the Works
Council at Nephrocare Mönchengladbach GmbH (Care Delivery)
- Ralf Erkens, Union
representative of IGBCE
- Regina Karsch, Union representative of IGBCE
- Dr Manuela Stauss-Grabo, Vice President Global
Biomedical Evidence Generation at Fresenius Medical Care's Global
Medical Office (representative of the executive employees in
Germany)
Michael Sen, Chairman of
the Supervisory Board of Fresenius Medical Care AG, says: "The
proposed employee representatives provide a broad range of
experience and knowledge to the Supervisory Board. I look forward
to a trusted and constructive collaboration to pursue our common
goal to further developing Fresenius Medical Care successfully to
the benefit patients, employees and shareholders."
Following the appointment, Fresenius Medical Care is preparing
the election of the employee representatives to the Supervisory
Board, following legal requirements. The election is expected to be
completed in the second half of 2024.
About Fresenius Medical Care:
Fresenius Medical Care is the world's leading provider of products
and services for individuals with renal diseases of which around
3.9 million patients worldwide regularly undergo dialysis
treatment. Through its network of 4,050 dialysis clinics, Fresenius
Medical Care provides dialysis treatments for approximately 344,000
patients around the globe and is the leading provider of dialysis
products such as dialysis machines and dialyzers. Fresenius Medical
Care is listed on the Frankfurt Stock Exchange (FME) and on the New
York Stock Exchange (FMS).
For more information visit the company's website
at www.freseniusmedicalcare.com.
Disclaimer:
This release contains forward-looking statements that are subject
to various risks and uncertainties. Actual results could differ
materially from those described in these forward-looking statements
due to various factors, including, but not limited to, changes in
business, economic and competitive conditions, legal changes,
regulatory approvals, impacts related to the COVID-19 pandemic
results of clinical studies, foreign exchange rate fluctuations,
uncertainties in litigation or investigative proceedings, and the
availability of financing. These and other risks and uncertainties
are detailed in Fresenius Medical Care's reports filed with the
U.S. Securities and Exchange Commission. Fresenius Medical Care
does not undertake any responsibility to update the forward-looking
statements in this release.
Media contact
Christine
Peters
T +49 160 60 66 770
christine.peters@freseniusmedicalcare.com
Contact for analysts and investors
Ilia Kürten
T +49 6172 268 59 66
ilia.kuerten@freseniusmedicalcare.com
www.freseniusmedicalcare.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/fresenius-medical-care-ag-nominates-six-employee-representatives-to-the-supervisory-board-302053359.html
SOURCE Fresenius Medical Care Holdings, Inc.